Zhejiang Taimei Medical Technology Co., Ltd. (2576.HK)
- Previous Close
3.450 - Open
3.300 - Bid 3.320 x --
- Ask 3.430 x --
- Day's Range
3.300 - 3.320 - 52 Week Range
3.020 - 11.680 - Volume
2,800 - Avg. Volume
76,279 - Market Cap (intraday)
1.872B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.420 - Earnings Date Mar 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.65
Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders. It offers software solutions, such as eCooperate, a clinical trial project management system; eArchives, an electric trail master file; eCollect, an electronic data capture system; eCollege, a training management system; eQuality, a quality audit system; eBalance, an interactive Web-based response system; eOutcomes, a subject remote management system; eTime, a time management system; and eImage, a medical image reading system. It also provides hospital software, including eTrial, a phase I ward management system; eSite, a clinical trial management system; eMonitor, a remote site management system; eScreening, a subject screening system; GCP-X, an intelligent clinical trial platform; and IIT-EDC, a clinical research data collection system. In addition, the company offers pharmacovigilance software solutions, such as eSafety global pharmacovigilance system; and eSAE, a drug safety information communication ad management system. Further, it provides marketing software and digital innovation solutions. The company was founded in 2013 and is headquartered in Jiaxing, China.
www.taimei.com627
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2576.HK
View MorePerformance Overview: 2576.HK
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2576.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2576.HK
View MoreValuation Measures
Market Cap
1.95B
Enterprise Value
685.53M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.15
Price/Book (mrq)
1.55
Enterprise Value/Revenue
1.15
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-38.94%
Return on Assets (ttm)
-10.94%
Return on Equity (ttm)
-19.10%
Revenue (ttm)
551.16M
Net Income Avi to Common (ttm)
-214.61M
Diluted EPS (ttm)
-0.420
Balance Sheet and Cash Flow
Total Cash (mrq)
978.7M
Total Debt/Equity (mrq)
1.34%
Levered Free Cash Flow (ttm)
-96.38M